Stevens-johnson syndrome and toxic epidermal necrolysis: A retrospective evaluation;Stevens-johnson sendromu ve toksik epidermal nekroliz: Retrospektif bir deǧerlendirme

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 43, Issue 1, 2009, Pages 15-20

  Dicle, Özlem ^a   Yilmaz, Ertan ^a   Alpsoy, Erkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Drug eruptions; Stevens johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; AMIFOSTINE; AMPICILLIN; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; CYTARABINE; DICLOFENAC; FOLINIC ACID; IBUPROFEN; INDOMETACIN; LAMOTRIGINE; MELOXICAM; METHOTREXATE; NAPROXEN; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; SALAZOSULFAPYRIDINE; VALPROIC ACID;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEATH; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PROGNOSIS; RETROSPECTIVE STUDY; SEPSIS; STEVENS JOHNSON SYNDROME; SURVIVAL RATE; TOXIC EPIDERMAL NECROLYSIS;

EID: 63049090031     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Roujeau JC, Stern R: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
2. Auquier-Dunant A, Mockenhaupt M, Naldi L et al: Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002;138:1019-24.
3. Bastuji-Garin S, Rzany B, Stern RS et al: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
4. Viard I, Wehrli P, Bullani R et al: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
5. Roujeau JC: Drug-induced toxic epidermal necrolysis. II. Current aspects. Clin Dermatol 1993;11:493-500.
6. Roujeau JC, Kelly JP, Naldi L et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
7. Mockenhaupt M, Messenheimer J, Tennis P et al: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepilectics. Neurology 2005;64:1134-8.
8. Akman A, Alpsoy E: Eritema Multiforme, Steven-Johnson Sendromu ve Toksik Epidermal Nekroliz (Lyell Sendromu). Türkiye Klinikleri J Surg Med Sci 2006;2:6-15.
9. Bastuji-Garin S, Fouchard N, Bertocchi M et al: SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-153.
10. Roujeau JC, Guillaume JC, Fabre JP et al: Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990;126:37-42.
11. French LE: Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergology International 2006;55:9-16.
12. Schopf E, Stuhmer A, Rzany B et al: Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.
13. De Rojas MV, Dart JKG, Saw VPJ: The natural history of Stevens- Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophtalmol 2007;91:1048-53.
14. Pereira FA, Mudgil AV, Rosmarin D: Toxic epidermal necrolysis. J Am Acad Dermatol 2007;56:181-200.
15. Yalcin B, Karaduman A: Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid. J Am Acad Dermatol 2000;43:898-9.
16. Uǧuz A, Berber Z, Haspolat Ş ve ark: Lamotrijine baǧl? Stevens- Johnson sendromu-toksik epidermal nekroliz: bir olgu sunumu. Türkiye Klinikleri J Pediatr 2005;14:36-9.
17. Janinis J, Panagos G, Panousaki A et al: Stevens-Johnson syndrome and epidermal necrolysis after administration of sodium phenytoin with cranial irradiation. Eur J Cancer 1993;29A:478-9.
18. Duncan KO, Tigelaar RE, Bolognia JL: Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol 1999;40:493-6.
19. Khafaga YM, Jamshed A, Alam AAK et al: Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncologica 1999;38:111-6.
20. Fleischer AB, Rosenthal DI, Bernard SA et al: Skin reactions to radiotherapy- a spectrum resembling erythema multiforme: case report and review of the literature. Cutis 1992;49:35-9.
21. Atahan L?, Özyar E, Sahin S et al: Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly inducid by amifostine during raiotherapy. Br J Dermatol 2000;143:1072-3.
22. Demiral AN, Yerebakan O, Şimşir V ve ark: Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report. Jpn J Clin Oncol 2002;32:477-9.
23. Valeyrie-Allanore L, Poulalhon N, Fagot JP et al: Stevens- Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol 2008;87:300-3.
24. Doval-Garcia I, LeCleach L, Bocquet H et al: Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000;136:323-7.
25. Schneck J, Fagot JP, Sekula P et al: Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 2008;58:33-40.
26. Guibal F, Bastuji-Garin S, Chosidow O et al: Characteristics of toxic epidermal necrolysis inpatients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995;131:669-72.
27. Martinez AE, Atherton DJ: High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol 2000;17:87-90.
28. Kardaun SH, Jonkman MF: Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87:144-8.
29. Prins C, Vittorio C, Padilla RS et al: Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology 2003;207:96-9.
30. Tükenmez G, Mansur AT, Tütüncü D ve ark: Toksik epidermal nekrolizde intravenöz immnglobulin tedavisi: iki olgu sunumu. TÜRKDERM 2005;39:136-41.